Breast Cancer Awareness Month 2026

Every Story Is Unique. Every Journey Matters.

Behind every diagnosis is a deeply personal story of courage, resilience, and hope. No two journeys are alike. Breast cancer affects women and their families differently around the world, and every experience deserves compassion, dignity, and support.

This year's theme also reminds us that quality care must be inclusive, regardless of where someone lives or what they earn. It calls on us to honor the diversity of experiences while working together to close gaps in early detection, timely diagnosis, and effective treatment.

The Global Picture

Breast cancer is the most commonly diagnosed cancer among women worldwide. In 2022, an estimated 2.3 million women were diagnosed, and more than 500,000 died from the disease. Behind these numbers are mothers, sisters, daughters, and friends.

Decades of progress show what is possible when science, early detection, and high-quality care come together. But those gains have not reached everyone equally:

• Breast cancer mortality among American Indian and Alaska Native women has not declined in the past 30 years.

• Black women are 37% more likely to die of breast cancer than white women, despite a lower incidence rate.

• Resistance to existing therapies continues to let the disease spread and become fatal for tens of thousands of people in the U.S. each year.

Research Progress in 2026

On February 2, 2026, Susan G. Komen®, the world's leading breast cancer organization, released its 2026 Breast Cancer Progress Outlook. The U.S. breast cancer death rate has fallen 44% from its 1989 peak to 2023, averting an estimated 670,000 deaths thanks largely to better treatment and earlier detection through screening.

Three areas are driving new hope for patients:

• Oral treatments for metastatic hormone receptor-positive breast cancer. Pills known as selective estrogen receptor degraders (SERDs) can be taken at home, offering an easier alternative to long-standing injected treatments.

• Antibody-drug conjugates (ADCs). These next-generation therapies use lab-made antibodies to deliver chemotherapy directly to cancer cells. Early results show they can be highly effective and more targeted.

• Liquid biopsies (ctDNA and MRD testing). Simple blood tests can detect tiny traces of cancer DNA in the bloodstream, helping doctors monitor and respond to the disease sooner.

Get Involved

Taking part in awareness campaigns is a great way to learn about breast cancer and its impact on our communities. Whether you join locally or globally, there is a way to participate:

• Join a nationwide movement: SurvivingBreastCancer.org's October fundraiser, Tell Cancer to Go Take a Hike.

• Connect from home: BreastCancer.org's public community discussion forums offer support and conversation from the comfort of your own home.

Breast Cancer Walk Event | Join. Fundraise. Support.

Home - Community Discussion Forums

Smriti Goel, MD
October 26, 2026